Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Adenocarcinoma of the Prostate Stage II”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00450749
What this trial is testing

Lycopene in Treating Patients Undergoing Radical Prostatectomy for Prostate Cancer

Who this might be right for
Adenocarcinoma of the ProstateStage I Prostate CancerStage II Prostate Cancer+1 more
National Cancer Institute (NCI) 10
Testing effectiveness (Phase 2)Study completedNCT03279250
What this trial is testing

Apalutamide and Gonadotropin-Releasing Hormone Analog With or Without Abiraterone Acetate in Treating Participants With Prostate Cancer

Who this might be right for
Prostate AdenocarcinomaStage IIB Prostate Cancer AJCC v8Stage IIC Prostate Cancer AJCC v8+2 more
M.D. Anderson Cancer Center 86
Testing effectiveness (Phase 2)Study completedNCT00684905
What this trial is testing

Leuprolide, Bicalutamide, and Implant Radiation Therapy in Treating Patients With Locally Recurrent Prostate Cancer After External-Beam Radiation Therapy

Who this might be right for
Prostate Cancer
Mayo Clinic 50
Large-scale testing (Phase 3)Study completedNCT02678351
What this trial is testing

68Ga-PSMA-11 PET/MRI in Finding Tumors in Patients With Intermediate or High-Risk Prostate Cancer Undergoing Surgery

Who this might be right for
Stage II Prostate AdenocarcinomaStage III Prostate Adenocarcinoma
Andrei Iagaru 74
Testing effectiveness (Phase 2)Study completedNCT00046826
What this trial is testing

Docetaxel, Estramustine, and Thalidomide in Treating Patients With Prostate Cancer Previously Treated With Hormone Therapy

Who this might be right for
Prostate Cancer
Nuvance Health
Large-scale testing (Phase 3)Ended earlyNCT00651326
What this trial is testing

Androgen Suppression and Radiation With/Out Docetaxel in High-Risk Localized Prostate Cancer

Who this might be right for
Prostate Cancer
NCIC Clinical Trials Group 48
Large-scale testing (Phase 3)Study completedNCT00002633
What this trial is testing

Hormone Therapy With or Without Surgery or Radiation Therapy in Treating Patients With Prostate Cancer

Who this might be right for
Prostate Cancer
NCIC Clinical Trials Group 361
Testing effectiveness (Phase 2)Study completedNCT00085228
What this trial is testing

Docetaxel With or Without Oblimersen in Treating Patients With Hormone-Refractory Adenocarcinoma (Cancer) of the Prostate

Who this might be right for
Prostate Cancer
European Organisation for Research and Treatment of Cancer - EORTC 116
Large-scale testing (Phase 3)Study completedNCT00423475
What this trial is testing

Radiation Therapy With or Without Goserelin in Treating Patients Who Have Undergone Surgery for Recurrent or Refractory Prostate Cancer

Who this might be right for
Prostate Cancer
UNICANCER 743
Not applicableActive Not RecruitingNCT06995053
What this trial is testing

Computed Tomography-Guided Stereotactic Body Radiation Therapy With Intrafraction Motion Monitoring for the Treatment of Localized Prostate Cancer, ILLUSION Trial

Who this might be right for
Localized Prostate AdenocarcinomaStage I Prostate Cancer AJCC v8Stage II Prostate Cancer AJCC v8+1 more
Jonsson Comprehensive Cancer Center 91
Testing effectiveness (Phase 2)Active Not RecruitingNCT03371719
What this trial is testing

Radiation Therapy With or Without Apalutamide in Treating Patients With Recurrent Prostate Cancer, the BALANCE Trial

Who this might be right for
Recurrent Prostate CarcinomaStage III Prostate Adenocarcinoma AJCC v7Stage IV Prostate Adenocarcinoma AJCC v7
NRG Oncology 298
Not applicableLooking for participantsNCT07276438
What this trial is testing

Image-Guidance and Online Adaptation With Stereotactic Body Radiation Therapy for the Treatment of Localized Prostate Cancer, MANTICORE Trial

Who this might be right for
Localized Prostate AdenocarcinomaStage I Prostate Cancer AJCC v8Stage II Prostate Cancer AJCC v8+1 more
Jonsson Comprehensive Cancer Center 186
Early research (Phase 1)Study completedNCT00450229
What this trial is testing

Diindolylmethane in Treating Patients Undergoing Surgery for Stage I or Stage II Prostate Cancer

Who this might be right for
Adenocarcinoma of the ProstateProstate CancerStage I Prostate Cancer+1 more
National Cancer Institute (NCI) 45
Testing effectiveness (Phase 2)Study completedNCT00025116
What this trial is testing

ZD 1839 in Treating Patients With Prostate Cancer That Has Not Responded to Hormone Therapy

Who this might be right for
Prostate Cancer
NCIC Clinical Trials Group 40
Testing effectiveness (Phase 2)Ended earlyNCT00321698
What this trial is testing

Radiation Therapy and Docetaxel in Treating Patients Who Are Undergoing Surgery for Localized Prostate Cancer

Who this might be right for
Prostate Cancer
OHSU Knight Cancer Institute 25
Testing effectiveness (Phase 2)Study completedNCT00976755
What this trial is testing

Everolimus as First-Line Therapy in Treating Patients With Prostate Cancer

Who this might be right for
Prostate Cancer
Swiss Cancer Institute 37
Testing effectiveness (Phase 2)Study completedNCT00002889
What this trial is testing

Radiation Therapy With Androgen Suppression in Treating Patients With Prostate Cancer

Who this might be right for
Prostate Cancer
Alliance for Clinical Trials in Oncology 180
Testing effectiveness (Phase 2)Study completedNCT01083368
What this trial is testing

Temsirolimus and Bevacizumab in Hormone-Resistant Metastatic Prostate Cancer That Did Not Respond to Chemotherapy

Who this might be right for
Prostate Cancer
Case Comprehensive Cancer Center 22
Large-scale testing (Phase 3)Active Not RecruitingNCT04134260
What this trial is testing

Testing the Addition of the Drug Apalutamide to the Usual Hormone Therapy and Radiation Therapy After Surgery for Prostate Cancer, INNOVATE Trial

Who this might be right for
Prostate AdenocarcinomaStage I Prostate Cancer AJCC v8Stage II Prostate Cancer AJCC v8+2 more
NRG Oncology 586
Testing effectiveness (Phase 2)Study completedNCT03456804
What this trial is testing

ESK981 in Treating Patients With Metastatic Castrate-Resistant Prostate Cancer

Who this might be right for
Castration Levels of TestosteroneCastration-Resistant Prostate CarcinomaMetastatic Prostate Carcinoma+2 more
Barbara Ann Karmanos Cancer Institute 13
Next Page